Enhanced Suppression of CD_4~+CD_(25)~+ Regulatory T Cells by Pregnant Level of Estrogen in Vitro
Chang Sheng
Abstract
Chang Sheng
Abstract
Objective To investigate whether the pregnant-level estrogen induce the expansion of CD4+CD25+ regulatory T cells and its suppression activity in vitro.Methods ① CD4+CD25+regulatory T cells labelled with CFSE were stimulated with anti-CD3 and anti-CD28 mAbs or PBS in the presence and absence of pregnant level estrogen(E2)(experimental group,control group A and control group B),or no any stimulus instead of PBS(placebo group).②CFSE-labelled CD4+CD25+ naive T cells were cultured with CD4+CD25+ regulatory T cells,which were pretreated for 2 hours with estrogen or not,and stimulated with anti-CD3 and anti-CD28 mAbs or PBS(experimental group,control group A and control group B).As placebo group,CFSE-labelled CD4+CD25+ naive T cells were treated only with PBS.After 120 hours,the proliferation of labelled cells was detected by FACS and analyzed by Modfit LT soft.Results Stimulated by anti-CD3 and anti-CD28 mAbs in 120 h,the proliferation index(PI) of CD4+CD25+regulatory T cells in experimental group were significantly higher than that in two control groups and placebo group.The proliferation of CFSE-labelled CD4+CD25+ naive T cells mediated with anti-CD3 and anti-CD28 mAbs was inhibited by CD4+CD25+regulatory T cells.estrogen pretreated CD4+CD25+regulatory T cells could further enhance this effect.Conclusion It suggested that high level of estrogen in gestation can induce the expansion of CD4+CD25+ regulatory T cells and enhance its suppression,and may play a pivotal role in the maternal-feto tolerance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate whether the pregnant-level estrogen induce the expansion of CD4+CD25+ regulatory T cells and its suppression activity in vitro.Methods ① CD4+CD25+regulatory T cells labelled with CFSE were stimulated with anti-CD3 and anti-CD28 mAbs or PBS in the presence and absence of pregnant level estrogen(E2)(experimental group,control group A and control group B),or no any stimulus instead of PBS(placebo group).②CFSE-labelled CD4+CD25+ naive T cells were cultured with CD4+CD25+ regulatory T cells,which were pretreated for 2 hours with estrogen or not,and stimulated with anti-CD3 and anti-CD28 mAbs or PBS(experimental group,control group A and control group B).As placebo group,CFSE-labelled CD4+CD25+ naive T cells were treated only with PBS.After 120 hours,the proliferation of labelled cells was detected by FACS and analyzed by Modfit LT soft.Results Stimulated by anti-CD3 and anti-CD28 mAbs in 120 h,the proliferation index(PI) of CD4+CD25+regulatory T cells in experimental group were significantly higher than that in two control groups and placebo group.The proliferation of CFSE-labelled CD4+CD25+ naive T cells mediated with anti-CD3 and anti-CD28 mAbs was inhibited by CD4+CD25+regulatory T cells.estrogen pretreated CD4+CD25+regulatory T cells could further enhance this effect.Conclusion It suggested that high level of estrogen in gestation can induce the expansion of CD4+CD25+ regulatory T cells and enhance its suppression,and may play a pivotal role in the maternal-feto tolerance.
Key concepts: IL-2 receptor, Estrogen, CD28, Endocrinology, Internal medicine, In vitro, Regulatory T cell, CD3